Pharmacogenetics & Pharmacogenomics

Pharmacogenetics is the study of how people's genetic makeup or genes influence how they respond to pharmacological therapy. Diet, overall health, and the environment all have an impact on drug reaction, but genetics is the strongest predictor of how you will take medication. The study of medication response variability owing to heredity is known as pharmacogenetics. The word 'pharmacogenomics' was coined more recently as a result of the trend of adding the suffix '... omics' to areas of research. While the former refers to genes that influence drug metabolism, the latter is a more general term that refers to all genes in the genome that influence drug response. Pharmacogenetics allows a healthcare provider to select the treatment and dose that is most likely to be effective for each particular patient. The one-size-fits-all approach to medicine selection and dosing that is currently used will one day be replaced by tailoring a patient's drug to their unique genetic traits. On an individual gene, therapeutic region, or drug basis, current pharmacogenetics knowledge can be examined.

Pharmacogenomics (also known as pharmacogenetics) is the study of how a person's genes impact how he or she reacts to drugs. Because of genetic variances, a medicine may be safe for one individual but dangerous for another. It may cause serious negative effects in certain people. Even if given the same dose, another person may not respond. Its long-term goal is to assist clinicians in selecting the medications and dosages that are optimal for each individual. Precision medicine is a branch of medicine that tries to treat each patient as an individual. Doctors currently prescribe medications based on a patient's age, weight, sex, and liver and kidney function. Researchers have discovered gene variations that alter how people react to a few medications. Doctors can choose the optimum drug and dose for each patient in these situations. Furthermore, understanding how individuals respond to drugs aids in identifying the various kinds of their disorders.

• Clinical Implementation of Pharmacogenomics
• Identification of Novel Genomic Targets for Drug Development
• Economics of Genome-Guided Interventions
• New Developments in The Genome Project
• Proteomics into Clinical Medicine, Pharmacology, And Therapeutics
• Genetic and Genomic Variation in Humans and Animals
• Xenobiotics